VC fund profile · evidence-aware directory data
AlleyCorp stages, portfolio and investment profile
Kevin Ryan's New York venture studio and early-stage fund that incubates companies and backs independent founders across applied AI, healthcare, deep tech, robotics, and economic infrastructure. AlleyCorp closed a $335M Fund II in July 2026.
Keep track of AlleyCorp
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$1M–$10M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Seed, Series A
Participates: Pre-Seed, Seed, Series A, Series B+
Sector focus
generalist-tech
Geography
140 W 22nd St, New York, NY 10010
Founded 2007
Fund size / AUM
$335M Fund II (2026)
A separate fund-size evidence record is not yet available.
Portfolio in our directory
7
Linked startup profiles
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Related reading
Recent investments, portfolio developments and our research on this investor.
Portfolio companies we track
Startups in our directory that list AlleyCorp as an investor (7 total).
- Alchemy Health End-to-end infrastructure for in-house pharmacy programs at HIV/HCV clinics.
- Clarasight AI operating system for enterprise travel and expense program management.
- Memora Health AI care navigation via SMS and phone for complex patients—acquired by Commure in 2024.
- Neno AI-native accounting, tax, and financial administration for European SMEs — agentic general ledger with accountants in the loop.
- Pearl Health Software for primary care practices participating in Medicare value-based care.
- Thyme Care Value-based oncology care navigation and support platform for cancer patients.
- Vanna Health Value-based technology-enabled care for serious mental illness (schizophrenia, bipolar).
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.